The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $44.55

Today's change-0.77 -1.70%
Updated August 31 4:00 PM EDT. Delayed by at least 15 minutes.
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $44.55

Today's change-0.77 -1.70%
Updated August 31 4:00 PM EDT. Delayed by at least 15 minutes.

Seattle Genetics Inc down (U.S.)$0.77

Seattle Genetics Inc closed sharply lower Wednesday, dropping (U.S.)$0.77 or 1.70% to (U.S.)$44.55. Shares have lost 1.26% over the last five days, but are unchanged over the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $45.14
  • Previous close(U.S.) $45.32
  • High(U.S.) $45.49
  • Low(U.S.) $44.49
  • Bid / Ask(U.S.) $36.19 / (U.S.) $0.00
  • YTD % change-0.74%
  • Volume433,507
  • Average volume (10-day)639,541
  • Average volume (1-month)672,578
  • Average volume (3-month)804,890
  • 52-week range(U.S.) $26.02 to (U.S.) $49.66
  • Beta1.86
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.76
Updated August 31 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue951119384
Total other revenue--------
Total revenue951119384
Gross profit851028374
Total cost of revenue10101010
Total operating expense129132119111
Selling / general / administrative33303430
Research & development86937571
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-33-21-25-27
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-33-20-25-26
Income after tax-33-20-25-26
Income tax, total--------
Net income-33-20-25-26
Total adjustments to net income--------
Net income before extra. items-33-20-25-26
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-33-20-25-26
Inc. avail. to common incl. extra. items-33-20-25-26
Diluted net income-33-20-25-26
Dilution adjustment--------
Diluted weighted average shares140140140128
Diluted EPS excluding extraordinary itemsvalue per share-0.23-0.15-0.18-0.21
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.23-0.15-0.18-0.21